Deliver Your News to the World

SmallCapNewsRelease:(OTC:AVIC) Begins Testing on Instant Detection Technology for H1N1


WEBWIRE

JERICHO, NY--(SmallCapNewsRelease)--December 16th, 2009, Aviso, Inc (OTC:AVIC) announced today that their subsidiary Diagnostic Nano Technology Corp.(DNA) will begin testing its, Instant Detect technology for the H1N1 instantly.

DNA said they are optimistic that the market is open to the Instant Detect product. DNA is in the beginning stages of development and testing and will continue to test the products ability to work on humans.

To view the entire press release, visit http://finance.yahoo.com/news/Diagnostic-Nano-Applications-iw-4260034057.html?x=0&.v=1

SmallCapNewsRelease gainers are Achillion Pharma (NASDAQ:ACHN) Superior Bancorp (NASDAQ:SUPR) Amarin Corp (NASDAQ:AMRN) First Bancorp Holding (NYSE:FBP) Delta Petroleum (NASDAQ:DPTR) Alliance Bankshares (NASDAQ:ABVA) Nature’s Sunshine Products (NASDAQ:NATR) Seven Arts Pictures (NASDAQ:SAPX)

SmallCapNewsRelease decliners are Helicos BioSciences Corp (NASDAQ:HLCS) PVF Capital Corp (NASDAQ:PVFC) AutoChina International (NASDAQ:AUTCW) Zion Oil & Gas (NASDAQ:ZNWAW) Retail Opportunity Investments (NASDAQ:ROICW) Cyclacel Pharma (NASDAQ:CYCC) Technitrol Inc (NYSE:TNL) EDAP TMS (NASDAQ:EDAP)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Small Cap News Release twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send no faxes or emails.



WebWireID109821




 
 AVIC
 H1N1 Swine Flu
 Small Cap News
 Penny Stock
 Aviso


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.